2023
Modes of type 2 immune response initiation
Kopp E, Agaronyan K, Licona-LimĂłn I, Nish S, Medzhitov R. Modes of type 2 immune response initiation. Immunity 2023, 56: 687-694. PMID: 37044059, DOI: 10.1016/j.immuni.2023.03.015.Peer-Reviewed Original Research
1994
Inhibition of NF-ÎşB by Sodium Salicylate and Aspirin
Kopp E, Ghosh S. Inhibition of NF-ÎşB by Sodium Salicylate and Aspirin. Science 1994, 265: 956-959. PMID: 8052854, DOI: 10.1126/science.8052854.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsAspirinCell LineEnhancer Elements, GeneticGene ExpressionGenes, ReporterHIV Long Terminal RepeatHIV-1HumansImmunoglobulin kappa-ChainsLipopolysaccharidesMiceNF-kappa BPhosphorylationPromoter Regions, GeneticProtein BiosynthesisProto-Oncogene ProteinsSodium SalicylateT-LymphocytesTranscription Factor RelBTranscription FactorsTransfectionTumor Cells, CulturedConceptsNF-kappa BInterleukin-1Anti-inflammatory drug sodium salicylateHuman immunodeficiency virus long terminal repeatNF-kappa B inhibitorSodium salicylateMechanism of actionLong terminal repeatIL-6T cellsNF-ÎşBAspirinAdhesion moleculesVirus long terminal repeatB inhibitorViral genesInhibitionDependent transcriptionInducible expressionSalicylateInflammationTranscription factorsInfectionTerminal repeat
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply